Stefano F Rimoldi1, Emrush Rexhaj1, Lorenza Pratali2, Damian M Bailey3, Damian Hutter4, Francesco Faita2, Carlos Salinas Salmòn5, Mercedes Villena5, Pascal Nicod6, Yves Allemann4, Urs Scherrer7, Claudio Sartori8. 1. Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland; Department of Internal Medicine and Botnar Center for Clinical Research, University Hospital, Lausanne, Switzerland. 2. Institute of Clinical Physiology, Pisa, Italy. 3. Neurovascular Research Laboratory, Faculty of Health, Science and Sport, University of Glamorgan, Pontypridd, Wales. 4. Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland. 5. Instituto Bolivano de Biologia de Altura, La Paz, Bolivia. 6. Department of Internal Medicine and Botnar Center for Clinical Research, University Hospital, Lausanne, Switzerland. 7. Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland; Facultad de Ciencias, Departamento de Biología, Universidad de Tarapacá, Arica, Chile. 8. Department of Internal Medicine and Botnar Center for Clinical Research, University Hospital, Lausanne, Switzerland. Electronic address: claudio.sartori@chuv.ch.
Abstract
BACKGROUND:Chronic mountain sickness (CMS) is a major public health problem characterized by exaggerated hypoxemia and erythrocytosis. In more advanced stages, patients with CMS often present with functional and structural changes of the pulmonary circulation, but there is little information on the systemic circulation. In patients with diseases associated with chronic hypoxemia at low altitude, systemic vascular function is altered. We hypothesized that patients with CMS have systemic vascular dysfunction that may predispose them to increased systemic cardiovascular morbidity. METHODS: To test this hypothesis, we assessed systemic endothelial function (by flow-mediated dilation [FMD]), arterial stiffness, and carotid intima-media thickness and arterial oxygen saturation (Sao(2)) in 23 patients with CMS without additional classic cardiovascular risk factors and 27 age-matched healthy mountain dwellers born and permanently living at 3,600 m. For some analyses, subjects were classified according to baseline Sao(2) quartiles; FMD of the highest quartile subgroup (Sao(2) ≥ 90%) was used as a reference value for post hoc comparisons. RESULTS:Patients with CMS had marked systemic vascular dysfunction as evidenced by impaired FMD (CMS, 4.6% ± 1.2%; control subjects, 7.6% ± 1.9%; P < .0001), greater pulse wave velocity (10.6 ± 2.1 m/s vs 8.4 ± 1.0 m/s, P < .001), and greater carotid intima-media thickness (690 ± 120 μm vs 570 ± 110 μm, P = .001). A positive relationship existed between Sao(2) and FMD (r = 0.62, P < .0001). Oxygen inhalation improved (P < .001) but did not normalize FMD in patients with CMS, although it normalized FMD in hypoxemic control subjects (Sao(2) < 90%) and had no detectable effect in normoxemic control subjects (Sao(2) ≥ 90%). CONCLUSIONS:Patients with CMS show marked systemic vascular dysfunction. Structural and functional alterations contribute to this problem that may predispose these patients to premature cardiovascular disease. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01182792; URL: www.clinicaltrials.gov.
RCT Entities:
BACKGROUND: Chronic mountain sickness (CMS) is a major public health problem characterized by exaggerated hypoxemia and erythrocytosis. In more advanced stages, patients with CMS often present with functional and structural changes of the pulmonary circulation, but there is little information on the systemic circulation. In patients with diseases associated with chronic hypoxemia at low altitude, systemic vascular function is altered. We hypothesized that patients with CMS have systemic vascular dysfunction that may predispose them to increased systemic cardiovascular morbidity. METHODS: To test this hypothesis, we assessed systemic endothelial function (by flow-mediated dilation [FMD]), arterial stiffness, and carotid intima-media thickness and arterial oxygen saturation (Sao(2)) in 23 patients with CMS without additional classic cardiovascular risk factors and 27 age-matched healthy mountain dwellers born and permanently living at 3,600 m. For some analyses, subjects were classified according to baseline Sao(2) quartiles; FMD of the highest quartile subgroup (Sao(2) ≥ 90%) was used as a reference value for post hoc comparisons. RESULTS:Patients with CMS had marked systemic vascular dysfunction as evidenced by impaired FMD (CMS, 4.6% ± 1.2%; control subjects, 7.6% ± 1.9%; P < .0001), greater pulse wave velocity (10.6 ± 2.1 m/s vs 8.4 ± 1.0 m/s, P < .001), and greater carotid intima-media thickness (690 ± 120 μm vs 570 ± 110 μm, P = .001). A positive relationship existed between Sao(2) and FMD (r = 0.62, P < .0001). Oxygen inhalation improved (P < .001) but did not normalize FMD in patients with CMS, although it normalized FMD in hypoxemic control subjects (Sao(2) < 90%) and had no detectable effect in normoxemic control subjects (Sao(2) ≥ 90%). CONCLUSIONS:Patients with CMS show marked systemic vascular dysfunction. Structural and functional alterations contribute to this problem that may predispose these patients to premature cardiovascular disease. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01182792; URL: www.clinicaltrials.gov.
Authors: Chantal Dedobbeleer; Alia Hadefi; Aurelien Pichon; Francisco Villafuerte; Robert Naeije; Philippe Unger Journal: Int J Cardiovasc Imaging Date: 2015-02-10 Impact factor: 2.357
Authors: Nia C S Lewis; Damian M Bailey; Gregory R Dumanoir; Laura Messinger; Samuel J E Lucas; James D Cotter; Joseph Donnelly; Jane McEneny; Ian S Young; Mike Stembridge; Keith R Burgess; Aparna S Basnet; Philip N Ainslie Journal: J Physiol Date: 2013-12-09 Impact factor: 5.182
Authors: Michael M Tymko; Justin S Lawley; Philip N Ainslie; Alexander B Hansen; Florian Hofstaetter; Simon Rainer; Sachin Amin; Gilbert Moralez; Christopher Gasho; Gustavo Vizcardo-Galindo; Daniela Bermudez; Francisco C Villafuerte; Christopher M Hearon Journal: Circ Res Date: 2020-04-09 Impact factor: 17.367
Authors: Jose R Espinoza; Giancarlo Alvarez; Fabiola León-Velarde; Hugo F Ju Preciado; Jose-Luis Macarlupu; Maria Rivera-Ch; Jorge Rodriguez; Judith Favier; Anne-Paule Gimenez-Roqueplo; Jean-Paul Richalet Journal: High Alt Med Biol Date: 2014-06 Impact factor: 1.981
Authors: L Madden Brewster; Anthony R Bain; Vinicius P Garcia; Hannah K Fandl; Rachel Stone; Noah M DeSouza; Jared J Greiner; Michael M Tymko; Gustavo A Vizcardo-Galindo; Romulo J Figueroa-Mujica; Francisco C Villafuerte; Philip N Ainslie; Christopher A DeSouza Journal: Am J Physiol Heart Circ Physiol Date: 2021-03-12 Impact factor: 4.733
Authors: Uday Yanamandra; S P Singh; Sushma Yanamandra; Deepak Mulajkar; R S Grewal; Shashibala Singh; M Z Ashraf; Prasanna Reddy; Velu Nair Journal: Med J Armed Forces India Date: 2017-11-15
Authors: Aldo De Ferrari; J Jaime Miranda; Robert H Gilman; Victor G Dávila-Román; Fabiola León-Velarde; Maria Rivera-Ch; Luis Huicho; Antonio Bernabé-Ortiz; Robert A Wise; William Checkley Journal: Chest Date: 2014-11 Impact factor: 9.410